161 related articles for article (PubMed ID: 36674782)
1. Increased Expression of the Δ133p53β Isoform Enhances Brain Metastasis.
Jesus ANB; Taha A; Wang D; Mehta PM; Mehta S; Reily-Bell A; Lekamlage SP; Saraiva AM; Tahmeedzaman T; Ziad F; Thotathil Z; Gan PYC; Royds J; Braithwaite A; Hung N; Slatter TL
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674782
[TBL] [Abstract][Full Text] [Related]
2. Elevation of the TP53 isoform Δ133p53β in glioblastomas: an alternative to mutant p53 in promoting tumor development.
Kazantseva M; Eiholzer RA; Mehta S; Taha A; Bowie S; Roth I; Zhou J; Joruiz SM; Royds JA; Hung NA; Slatter TL; Braithwaite AW
J Pathol; 2018 Sep; 246(1):77-88. PubMed ID: 29888503
[TBL] [Abstract][Full Text] [Related]
3. Activated CD90/Thy-1 fibroblasts co-express the Δ133p53β isoform and are associated with highly inflamed rheumatoid arthritis.
Wiles AK; Mehta S; Millier M; Woolley AG; Li K; Parker K; Kazantseva M; Wilson M; Young K; Bowie S; Ray S; Slatter TL; Stamp LK; Hessian PA; Braithwaite AW
Arthritis Res Ther; 2023 Apr; 25(1):62. PubMed ID: 37060003
[TBL] [Abstract][Full Text] [Related]
4. Δ133p53β isoform pro-invasive activity is regulated through an aggregation-dependent mechanism in cancer cells.
Arsic N; Slatter T; Gadea G; Villain E; Fournet A; Kazantseva M; Allemand F; Sibille N; Seveno M; de Rossi S; Mehta S; Urbach S; Bourdon JC; Bernado P; Kajava AV; Braithwaite A; Roux P
Nat Commun; 2021 Sep; 12(1):5463. PubMed ID: 34526502
[TBL] [Abstract][Full Text] [Related]
5.
Gadea G; Arsic N; Fernandes K; Diot A; Joruiz SM; Abdallah S; Meuray V; Vinot S; Anguille C; Remenyi J; Khoury MP; Quinlan PR; Purdie CA; Jordan LB; Fuller-Pace FV; de Toledo M; Cren M; Thompson AM; Bourdon JC; Roux P
Elife; 2016 Sep; 5():. PubMed ID: 27630122
[No Abstract] [Full Text] [Related]
6. The p53 isoform Δ133p53β promotes cancer stem cell potential.
Arsic N; Gadea G; Lagerqvist EL; Busson M; Cahuzac N; Brock C; Hollande F; Gire V; Pannequin J; Roux P
Stem Cell Reports; 2015 Apr; 4(4):531-40. PubMed ID: 25754205
[TBL] [Abstract][Full Text] [Related]
7. Conformational stability and dynamics of the cancer-associated isoform Δ133p53β are modulated by p53 peptides and p53-specific DNA.
Lei J; Qi R; Tang Y; Wang W; Wei G; Nussinov R; Ma B
FASEB J; 2019 Mar; 33(3):4225-4235. PubMed ID: 30540922
[TBL] [Abstract][Full Text] [Related]
8. The p53 isoform, Δ133p53α, stimulates angiogenesis and tumour progression.
Bernard H; Garmy-Susini B; Ainaoui N; Van Den Berghe L; Peurichard A; Javerzat S; Bikfalvi A; Lane DP; Bourdon JC; Prats AC
Oncogene; 2013 Apr; 32(17):2150-60. PubMed ID: 22733133
[TBL] [Abstract][Full Text] [Related]
9. αv-Integrin isoform expression in primary human tumors and brain metastases.
Vogetseder A; Thies S; Ingold B; Roth P; Weller M; Schraml P; Goodman SL; Moch H
Int J Cancer; 2013 Nov; 133(10):2362-71. PubMed ID: 23661241
[TBL] [Abstract][Full Text] [Related]
10. Association of Ki-67, p53, and bcl-2 expression of the primary non-small-cell lung cancer lesion with brain metastatic lesion.
Bubb RS; Komaki R; Hachiya T; Milas I; Ro JY; Langford L; Sawaya R; Putnam JB; Allen P; Cox JD; McDonnell TJ; Brock W; Hong WK; Roth JA; Milas L
Int J Radiat Oncol Biol Phys; 2002 Aug; 53(5):1216-24. PubMed ID: 12128123
[TBL] [Abstract][Full Text] [Related]
11. p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer.
Powell E; Shao J; Yuan Y; Chen HC; Cai S; Echeverria GV; Mistry N; Decker KF; Schlosberg C; Do KA; Edwards JR; Liang H; Piwnica-Worms D; Piwnica-Worms H
Breast Cancer Res; 2016 Jan; 18(1):13. PubMed ID: 26818199
[TBL] [Abstract][Full Text] [Related]
12. Expression of p53 isoforms in renal cell carcinoma.
Song W; Huo SW; Lü JJ; Liu Z; Fang XL; Jin XB; Yuan MZ
Chin Med J (Engl); 2009 Apr; 122(8):921-6. PubMed ID: 19493415
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Polo-like kinase 1 prevents the growth of metastatic breast cancer cells in the brain.
Qian Y; Hua E; Bisht K; Woditschka S; Skordos KW; Liewehr DJ; Steinberg SM; Brogi E; Akram MM; Killian JK; Edelman DC; Pineda M; Scurci S; Degenhardt YY; Laquerre S; Lampkin TA; Meltzer PS; Camphausen K; Steeg PS; Palmieri D
Clin Exp Metastasis; 2011 Dec; 28(8):899-908. PubMed ID: 21953073
[TBL] [Abstract][Full Text] [Related]
14. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
[TBL] [Abstract][Full Text] [Related]
15. The Δ133p53β isoform promotes an immunosuppressive environment leading to aggressive prostate cancer.
Kazantseva M; Mehta S; Eiholzer RA; Gimenez G; Bowie S; Campbell H; Reily-Bell AL; Roth I; Ray S; Drummond CJ; Reid G; Joruiz SM; Wiles A; Morrin HR; Reader KL; Hung NA; Baird MA; Slatter TL; Braithwaite AW
Cell Death Dis; 2019 Aug; 10(9):631. PubMed ID: 31431617
[TBL] [Abstract][Full Text] [Related]
16. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
[TBL] [Abstract][Full Text] [Related]
17. Metabolic advantages and vulnerabilities in brain metastases.
Ciminera AK; Jandial R; Termini J
Clin Exp Metastasis; 2017 Oct; 34(6-7):401-410. PubMed ID: 29063238
[TBL] [Abstract][Full Text] [Related]
18. Tumor suppressor role of cytoplasmic polyadenylation element binding protein 2 (CPEB2) in human mammary epithelial cells.
Tordjman J; Majumder M; Amiri M; Hasan A; Hess D; Lala PK
BMC Cancer; 2019 Jun; 19(1):561. PubMed ID: 31185986
[TBL] [Abstract][Full Text] [Related]
19. Cytoplasmic p53β Isoforms Are Associated with Worse Disease-Free Survival in Breast Cancer.
Steffens Reinhardt L; Groen K; Morten BC; Bourdon JC; Avery-Kiejda KA
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743117
[No Abstract] [Full Text] [Related]
20. Expression of p53, bcl-2, E-cadherin, matrix metalloproteinase-9, and tissue inhibitor of metalloproteinases-1 in paired primary tumors and brain metastasis.
Arnold SM; Young AB; Munn RK; Patchell RA; Nanayakkara N; Markesbery WR
Clin Cancer Res; 1999 Dec; 5(12):4028-33. PubMed ID: 10632335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
